Related Experiment Video

Updated: Jan 15, 2026

The Murine Choline-Deficient, Ethionine-Supplemented CDE Diet Model of Chronic Liver Injury
07:27

The Murine Choline-Deficient, Ethionine-Supplemented CDE Diet Model of Chronic Liver Injury

Published on: October 21, 2017

12.3K

[Prevention of decompensation in advanced chronic liver disease]

Marlene Reincke, Lukas Sturm, Robert Thimme

    Deutsche Medizinische Wochenschrift (1946)
    |October 10, 2025
    PubMed

    Insights

    Early intervention for clinically significant portal hypertension (CSPH) in advanced chronic liver disease (ACLD) is crucial. Non-selective beta-blockers can prevent decompensation, improving outcomes for liver patients.

    Area of Science:

    • Hepatology
    • Gastroenterology
    • Internal Medicine

    Background:

    • Advanced chronic liver disease (ACLD) progression to decompensation carries high mortality.
    • Clinically significant portal hypertension (CSPH), defined as hepatic venous pressure gradient (HVPG) ≥10 mmHg, is the primary driver of decompensation.
    • Preventing the initial decompensation event, particularly ascites, is a critical therapeutic objective.

    Purpose of the Study:

    • To highlight the importance of early identification and management of CSPH in ACLD.
    • To review the role of non-selective beta-blockers (NSBBs) in preventing decompensation.
    • To emphasize the impact of timely intervention on patient outcomes.

    Main Methods:

    • Literature review focusing on CSPH, decompensation, and therapeutic strategies in ACLD.
    • Analysis of studies evaluating non-invasive tools for risk identification (e.g., transient elastography).
    • Examination of clinical trial data on NSBBs, including carvedilol, for portal pressure reduction and decompensation prevention.

    Main Results:

    • CSPH is a critical determinant of decompensation in ACLD.
    • Non-invasive elastography aids in identifying at-risk patients.
    • NSBBs, such as carvedilol, effectively reduce portal pressure and prevent decompensation, irrespective of variceal status.
    • Lifestyle modifications and treating the underlying liver cause are fundamental.

    Conclusions:

    • Early detection and management of CSPH are vital for altering the natural history of cirrhosis.
    • Initiating therapy, including NSBBs, can significantly improve outcomes and reduce mortality in ACLD patients.
    • A multi-faceted approach combining pharmacological therapy, lifestyle changes, and addressing the root cause is essential for optimal patient care.

    More Related Videos

    Laparoscopic Anatomic S7+S8d Resection Preserving Inferior Right Hepatic Vein and S6 with Right Hepatic Vein Transection06:00

    Laparoscopic Anatomic S7+S8d Resection Preserving Inferior Right Hepatic Vein and S6 with Right Hepatic Vein Transection

    Published on: December 30, 2025

    44
    Author Spotlight: Advancements and Challenges in Machine Perfusion for Liver Transplantation05:25

    Author Spotlight: Advancements and Challenges in Machine Perfusion for Liver Transplantation

    Published on: June 14, 2024

    960

    Related Concept Videos

    Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

    Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

    Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
    212
    Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

    Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

    In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
    180
    Esophageal Varices-II: Clinical Features and Management01:28

    Esophageal Varices-II: Clinical Features and Management

    Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
    In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
    368
    Chronic Pancreatitis II: Collaborative Care01:29

    Chronic Pancreatitis II: Collaborative Care

    The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
    Assessment:
    311
    Chronic Kidney Disease IV: Nursing Management01:18

    Chronic Kidney Disease IV: Nursing Management

    Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of...
    321
    Heart Failure V: Medical Management01:30

    Heart Failure V: Medical Management

    Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
    218